2025-03-19 22:47:19
Latest Post
Syngene concludes the acquisition of Biologics Manufacturing Facility from Emergent BioSolutions Inc.
Suraj Estate Developers Ltd acquires Land Parcel at Shivaji Park, Dadar (West), Mumbai
Nawaz Modi Singhania steps down as Director
IKS Health wins additional Top Honors in 2025 Black Book Surveys in Clinical Documentation and Medical Coding
ZIM Laboratories Ltd receives Marketing Authorization for Dimethyl Fumarate (120 mg & 240 mg) Modified Release Capsules in Portugal, Europe
Stock Report
Josts Engineering Company Ltd Q3 FY2022-23 consolidated PAT higher at Rs. 2.17 crore
Posted On : 2023-02-07 19:33:03( TIMEZONE : IST )
has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 41.46 crores during the period ended December 31, 2022 as compared to Rs. 37.45 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 2.17 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 1.22 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 12 for the period ended December 31, 2022 as compared to Rs. 7 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹41.46 crs | ₹37.45 crs |  10.71% |
| Net Profit | ₹2.17 crs | ₹1.22 crs | 77.87% |
| EPS | ₹12 | ₹7 | 71.43% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.41.46 crores during the period ended December 31, 2022 as compared to Rs.34.82 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.2.17 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.1.88 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.12 for the period ended December 31, 2022 as compared to Rs.10 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹41.46 crs | ₹34.82 crs | 19.07% |
| Net Profit | ₹2.17 crs | ₹1.88 crs | 15.43% |
| EPS | ₹12 | ₹10 | 20.00% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.117.74 crores during the 9 Months period ended December 31, 2022 as compared to Rs.85.93 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.5.09 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.4.03 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.27 for the 9 Months period ended December 31, 2022 as compared to Rs.22 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹117.74 crs | ₹85.93 crs | 37.02% |
| Net Profit | ₹5.09 crs | ₹4.03 crs | 26.30% |
| EPS | ₹27 | ₹22 | 22.73% |
